Photobiomodulation is poised for a transformative shift in clinical application, with multicenter randomized trials targeting chronic pain, myopia progression, and post-stroke cognition set to launch. Standardized device parameters and a focus on biphasic dose-response curves aim to establish safe upper limits, enhancing the treatment's applicability across neurological, ophthalmological, and immunological fields. As evidence of its low-risk effectiveness strengthens, this therapy is on track to transition from experimental proof-of-concept to integration in mainstream medical practice.
“Medical-Grade Near-Infrared Light Therapy at Specific Frequencies Shows Promise for Protecting Football Players’ Brains”
“A preliminary study with 26 football players suggests that near-infrared light therapy could prevent brain inflammation caused by repetitive impacts.”
“But for players who used the device with an active near-infrared light, brain inflammation didn’t increase over the season.”
“The results are published in Journal of Neurotrauma as 'Transcranial Photobiomodulation Promotes Neurological Resilience in Current Collegiate American Football Players Exposed to Repetitive Head Acceleration Events.'”
Title not available for this citation.
“The meta-analysis found that children with myopia who got RLRL therapy in addition to normal treatment had significantly slower disease progression than the control group.”
Title not available for this citation.
“This meta-analysis included 1,053 participants: 515 in the RLRL and 538 in the control groups.”
Title not available for this citation.
“The SMD for SER reduction was 0.84 (95% CI: 0.50, 1.19)”
Title not available for this citation.
“We hypothesized that 650 nm red-light photobiomodulation (PBM) alleviates septic ALI by reprogramming myeloid responses and preserving mitochondrial function via adiponectin signaling.”
Title not available for this citation.
“PBM prolonged survival, reduced lung edema, improved histopathology, and lowered systemic TNF-α, IL-6, IL-1β, and MCP-1.”
Title not available for this citation.
“PBM elevated adiponectin in serum, BALF, and lung; AdipoR1 knockdown abrogated anti-inflammatory effects and myeloid rebalancing.”
Title not available for this citation.
“PBM therapy did not demonstrate a significant benefit for reducing perineal pain or improving wound healing after episiotomy compared with control interventions.”
Title not available for this citation.
“GRADE for both pain and wound-healing outcomes was rated as very low.”